Relationship between Salivary Amylase and Xerostomia in Intensity-Modulated Radiation Therapy for Head and Neck Cancer: A Prospective Pilot Study

Autor: Francesca De Felice, Maria Giulia Scarabelli, Raffaella De Pietro, Giuseppina Chiarello, Federico Di Giammarco, Carlo Guglielmo Cattaneo, Giuliana Lombardo, Francesca Romana Montinaro, Miriam Tomaciello, Mario Tombolini, Daniela Messineo, Pier Luigi Di Paolo, Claudia Marchetti, Daniela Musio, Vincenzo Tombolini

Publikováno v: Current Oncology, Vol 29, Iss 9, Pp 6564-6572 (2022)

Purpose. A single-institution prospective pilot study was conducted to the assess correlation between salivary amylase and xerostomia in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiotherapy (IMRT).

Externí odkaz: https://doaj.org/article/38b3fb8e22ae4f77933b09dcc5815208

NLR and BRCA mutational status in patients with high grade serous advanced ovarian cancer

Autor: Claudia Marchetti, Marco D’Indinosante, Carolina Bottoni, Chiara Di Ilio, Stefano Di Berardino, Barbara Costantini, Angelo Minucci, Laura Vertechy, Giovanni Scambia, Anna Fagotti

Publikováno v: Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)

Abstract Laboratory-markers of the systemic inflammatory-response, such as neutrophil/lymphocyte-ratio (NLR) have been studied as prognostic factors in several tumors but in OC-patients their role is still controversial and no data about the possible

Externí odkaz: https://doaj.org/article/7ac325423fbd40e8b6a886986321c46c

Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer

Autor: Carmine Conte, Claudia Marchetti, Matteo Loverro, Maria Teresa Giudice, Andrea Rosati, Valerio Gallotta, Giovanni Scambia, Anna Fagotti

Publikováno v: International Journal of Gynecologic Cancer. 33:137-144

ObjectiveRetrospective series have shown minimally invasive secondary cytoreductive surgery is a feasible approach in selected cases of recurrent ovarian cancer. However, no predictors of minimally invasive secondary cytoreductive surgery feasibility

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c20541901c9048f03f50415fe3c64a91
https://doi.org/10.1136/ijgc-2022-003904

Trabectedin plus pegylated liposomal doxorubicin in patients with disease progression after PARP inhibitor maintenance: a real-life case–control study

Autor: Laura Vertechy, Serena Maria Boccia, Giordana Tiberi, Giacomo Avesani, Giacomo Corrado, Anna Fagotti, Giovanni Scambia, Claudia Marchetti

Publikováno v: International Journal of Gynecologic Cancer. 33:243-249

ObjectivePoly (ADP-ribose) polymerase (PARP) inhibitor resistance is problematic in epithelial ovarian cancer management and sequencing strategies may be performed to overcome this issue. In this context, our study evaluated the role of non-platinum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc26713cb534adc74a2d6545e7de0363
https://doi.org/10.1136/ijgc-2022-003764

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women

Autor: Denise R. Nebgen, Susan M. Domchek, Joanne Kotsopoulos, Joanne A. de Hullu, Emma J. Crosbie, Vincent Singh Paramanandam, Monique M.A. Brood ‐ van Zanten, Barbara M. Norquist, Theresa Guise, Serge Rozenberg, Allison W. Kurian, Holly J. Pederson, Nese Yuksel, Rachel Michaelson‐Cohen, Sharon L. Bober, Agnaldo Lopes da Silva Filho, Nora Johansen, F. Guidozzi, D. Gareth Evans, Usha Menon, Sheryl A. Kingsberg, C. Bethan Powell, Giovanni Grandi, Claudia Marchetti, Michelle Jacobson, Donal J. Brennan, Martha Hickey

Publikováno v: Nebgen, D R, Domchek, S M, Kotsopoulos, J, de Hullu, J A, Crosbie, E J, Paramanandam, V S, van Zanten, M B, Norquist, B M, Guise, T, Rozenberg, S, Kurian, A W, Pederson, H J, Yuksel, N, Michaelson-Cohen, R, Bober, S L, da Silva Filho, A L, Johansen, N, Guidozzi, F, Evans, D G, Menon, U, Kingsberg, S A, Powell, C B, Grandi, G, Marchetti, C, Jacobson, M, Brennan, D J & Hickey, M 2023, ' Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women : Scoping review and international consensus recommendations ', BJOG: An International Journal of Obstetrics & Gynaecology . https://doi.org/10.1111/1471-0528.17511

Women at high inherited risk of ovarian cancer are offered risk-reducing salpingo-oophorectomy (RRSO) from age 35 to 45 years. Although potentially life-saving, RRSO may induce symptoms that negatively affect quality of life and impair long-term heal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b717e05d371e0e4e6d12aff74403e65
http://www.scopus.com/inward/record.url?scp=85158081710&partnerID=8YFLogxK